| Literature DB >> 31747612 |
Sheetal Uppal1, Anne Gegonne1, Qingrong Chen2, Petria S Thompson1, Dan Cheng1, Jie Mu1, Daoud Meerzaman2, Hari S Misra3, Dinah S Singer4.
Abstract
The bromodomain protein 4 (BRD4) is an atypical kinase and histone acetyl transferase (HAT) that binds to acetylated histones and contributes to chromatin remodeling and early transcriptional elongation. During transcription, BRD4 travels with the elongation complex. Since most alternative splicing events take place co-transcriptionally, we asked if BRD4 plays a role in regulating alternative splicing. We report that distinct patterns of alternative splicing are associated with a conditional deletion of BRD4 during thymocyte differentiation in vivo. Similarly, the depletion of BRD4 in T cell acute lymphoblastic leukemia (T-ALL) cells alters patterns of splicing. Most alternatively spliced events affected by BRD4 are exon skipping. Importantly, BRD4 interacts with components of the splicing machinery, as assessed by both immunoprecipitation (IP) and proximity ligation assays (PLAs), and co-localizes on chromatin with the splicing regulator, FUS. We propose that BRD4 contributes to patterns of alternative splicing through its interaction with the splicing machinery during transcription elongation.Entities:
Keywords: AML; BET; BRD4; FUS; alternative splicing; thymocyte differentiation
Mesh:
Substances:
Year: 2019 PMID: 31747612 PMCID: PMC6893865 DOI: 10.1016/j.celrep.2019.10.066
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423